Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Discrete, Iterative Type I Polyketide Synthase System Catalyzing the Formation of Unusual Fatty Acid Chains.

Journal of the American Chemical Society·2026
Same author

High-Throughput Prediction of Protein-Protein Interactions Uncovers Hidden Molecular Networks in Biosynthetic Gene Clusters.

Computational and structural biotechnology journal·2026
Same author

Baxdrostat versus osilodrostat: steroid biosynthesis in human adrenocortical cells.

Endocrine connections·2026
Same author

Identification of <i>BRCA2</i> Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas.

Oncology research·2026
Same author

Barriers and facilitators for online genetic care for hereditary cancer in Japan: findings from surveys of both clients and medical professionals.

International journal of clinical oncology·2026
Same author

LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC.

Nature communications·2026

Related Experiment Video

Updated: May 25, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.5K

IER5 Promotes Ovarian Cancer Cell Proliferation and Peritoneal Dissemination.

Jayaraman Krishnaraj1, Sayaka Ueno2, Moe Nakamura1,3

  • 1Laboratory of Fundamental Oncology, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

Cancers
|February 26, 2025
PubMed
Summary

Immediate early response 5 (IER5) gene overexpression drives ovarian cancer (OC) proliferation and spread by activating heat shock factor-1 (HSF1). IER5 family genes may serve as diagnostic markers and therapeutic targets for OC.

Keywords:
HSF1HSPIER5metastasisovarian cancer

More Related Videos

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
08:54

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

Published on: February 17, 2012

14.4K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.5K

Related Experiment Videos

Last Updated: May 25, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.5K
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
08:54

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

Published on: February 17, 2012

14.4K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.5K

Area of Science:

  • Gynecological oncology
  • Molecular biology
  • Cancer research

Background:

  • Ovarian cancer (OC) is a highly lethal gynecological malignancy with poor survival rates, particularly in advanced stages, due to diagnostic challenges.
  • High-grade serous carcinoma, the most common OC subtype, frequently harbors p53 mutations.
  • The immediate early response 5 (IER5) gene, a p53 target, is found to be overexpressed in OC, but its role remains unclear.

Purpose of the Study:

  • To investigate the molecular mechanism of IER5 in ovarian cancer.
  • To determine the relationship between IER5, heat shock factor-1 (HSF1), and ovarian cancer progression.
  • To evaluate the potential of IER5 as a diagnostic marker and therapeutic target for OC.

Main Methods:

  • Quantitative analysis of IER5 mRNA expression in normal ovarian cells versus various OC cell lines (MOV, ID8G, HM-1).
  • Comparison of IER5 expression in OC cells from ascites versus parental cell lines.
  • Gene knockdown and overexpression experiments to assess the impact of IER5 and HSF1 on HSP expression and cell proliferation.

Main Results:

  • IER5 mRNA expression was significantly higher in OC cells compared to normal ovarian cells.
  • OC cells in ascites exhibited elevated IER5 expression.
  • IER5 knockdown inhibited HSP upregulation and OC cell proliferation, while IER5 overexpression enhanced HSP upregulation.
  • HSF1 knockdown mirrored the effects of IER5 knockdown, indicating its crucial role.

Conclusions:

  • The IER5-HSF1 pathway is implicated in the proliferation and peritoneal dissemination of OC cells.
  • Elevated expression of IER5 family genes correlates with poorer OC patient prognosis.
  • IER5 family genes represent promising diagnostic markers and potential therapeutic targets for ovarian cancer.